Prime Medicine, Inc.
PRME
$3.67
$0.000.00%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 177.68M | 213.29M | 101.75M | 144.26M | 190.44M |
| Total Receivables | -- | -- | 120.00K | 17.00K | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.94M | 2.49M | 3.03M | 2.95M | 6.78M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 674.00K | 15.63M | 16.39M | 16.54M | 14.67M |
| Total Current Assets | 181.29M | 231.41M | 121.29M | 163.77M | 211.89M |
|
|
|||||
| Total Current Assets | 181.29M | 231.41M | 121.29M | 163.77M | 211.89M |
| Net Property, Plant & Equipment | 146.75M | 139.92M | 144.03M | 150.34M | 71.56M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 14.69M | 13.69M | 13.69M | 14.06M | 14.06M |
| Total Assets | 342.73M | 385.01M | 279.01M | 328.16M | 297.51M |
|
|
|||||
| Total Accounts Payable | 8.89M | 9.35M | 6.38M | 10.03M | 11.35M |
| Total Accrued Expenses | 10.90M | 8.94M | 11.04M | 6.16M | 11.82M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 8.14M | 7.71M | 7.26M | 6.86M | 3.61M |
| Total Finance Division Other Current Liabilities | 9.53M | 9.01M | 9.43M | 11.25M | 11.18M |
| Total Other Current Liabilities | 9.53M | 9.01M | 9.43M | 11.25M | 11.18M |
| Total Current Liabilities | 37.45M | 35.02M | 34.11M | 34.29M | 37.96M |
|
|
|||||
| Total Current Liabilities | 37.45M | 35.02M | 34.11M | 34.29M | 37.96M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 108.29M | 110.42M | 112.48M | 114.29M | 37.18M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 76.13M | 77.75M | 71.56M | 72.66M | 69.22M |
| Total Liabilities | 221.87M | 223.19M | 218.15M | 221.24M | 144.36M |
|
|
|||||
| Common Stock & APIC | 1.01B | 1.00B | 852.56M | 846.04M | 840.36M |
| Retained Earnings | -888.35M | -842.28M | -791.69M | -739.10M | -687.21M |
| Treasury Stock & Other | 82.00K | 33.00K | -10.00K | -15.00K | 1.00K |
| Total Common Equity | 120.87M | 161.82M | 60.86M | 106.92M | 153.15M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 120.87M | 161.82M | 60.86M | 106.92M | 153.15M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 120.87M | 161.82M | 60.86M | 106.92M | 153.15M |
|
|
|||||